MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways

Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of oncology 2016-09, Vol.49 (3), p.1155-1163
Hauptverfasser: Sun, Pengcheng, Wang, Lu, Lu, Yunhan, Liu, Yuwei, Li, Lechen, Yin, Luyao, Zhang, Cheng, Zhao, Weiming, Shen, Baozhong, Xu, Wanhai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1163
container_issue 3
container_start_page 1155
container_title International journal of oncology
container_volume 49
creator Sun, Pengcheng
Wang, Lu
Lu, Yunhan
Liu, Yuwei
Li, Lechen
Yin, Luyao
Zhang, Cheng
Zhao, Weiming
Shen, Baozhong
Xu, Wanhai
description Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we used qRT-PCR to detect the expression of miR-195 in ccRCC tissues and normal kidney tissues. MTT assay was performed to detect the cell viability of miR-195. Migration and invasion were evaluated by Transwell migration and Matrigel invasion assays, respectively. Additionally, apoptosis levels were evaluated using TUNEL assays, and signaling pathway changes were determined by western blot analysis. We observed that miR-195 was downregulated in clear cell renal cell carcinoma samples compared with normal renal samples. We identified that overexpression of miR-195 inhibited ACHN cell viability, migration, invasion, and it also induced cell apoptosis by targeting VEGFR2 via PI3K/Akt and Raf/MEK/ERK signaling pathways. These findings indicate that miR-195 has a tumor suppressive role in ACHN cells and miR-195 may be a promising candidate target for prevention and treatment of renal cell carcinoma.
doi_str_mv 10.3892/ijo.2016.3608
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1932323413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A463756421</galeid><sourcerecordid>A463756421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-d034eeb9359ea03c243b5cd0709d4690365dd0e2e265f2967f64cf10702209853</originalsourceid><addsrcrecordid>eNptkV1v0zAUhiMEYmNwyS2yhARXaf2d-jKqug91G6gCbi03cVqXJM58nKHt18-lYzAJnQtbPs975KMny94TPGEzRadu5ycUEzlhEs9eZMekUCSnnLKX6Y6JyiVn6ih7A7DDmAqByevsiBaioLRgx9n9lauCX12XOVECRRM2NgL6sTg7XVFk-hptDSCD4tj5gGAchmAB3K1FwbcWuR6V8_NrVNm2BXTrDPp6wZbT8mf8nV2ZZnq1WE4XqyUCt-lN6_oNGkzc_jJ38DZ71ZgW7LvH8yT7frr4Nj_PL7-cXczLy7ziCse8xoxbu1ZMKGswqyhna1HVuMCq5lJhJkVdY0stlaKhShaN5FVDUp9SrGaCnWQfD3OH4G9GC1Hv_BjSZ0ATxWgqTthfamNaq13f-BhM1TmodMklK4TklCRq8h8qVW07V_neNi69Pwt8-iewtaaNW_DtGJ3v4TmYH8CkAyDYRg_BdSbcaYL13rROpvXetN6bTvyHx63GdWfrJ_qP2gR8PgAwJBeu9vDEpEk5VzlmOSFCsAelVaqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932323413</pqid></control><display><type>article</type><title>MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sun, Pengcheng ; Wang, Lu ; Lu, Yunhan ; Liu, Yuwei ; Li, Lechen ; Yin, Luyao ; Zhang, Cheng ; Zhao, Weiming ; Shen, Baozhong ; Xu, Wanhai</creator><creatorcontrib>Sun, Pengcheng ; Wang, Lu ; Lu, Yunhan ; Liu, Yuwei ; Li, Lechen ; Yin, Luyao ; Zhang, Cheng ; Zhao, Weiming ; Shen, Baozhong ; Xu, Wanhai</creatorcontrib><description>Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we used qRT-PCR to detect the expression of miR-195 in ccRCC tissues and normal kidney tissues. MTT assay was performed to detect the cell viability of miR-195. Migration and invasion were evaluated by Transwell migration and Matrigel invasion assays, respectively. Additionally, apoptosis levels were evaluated using TUNEL assays, and signaling pathway changes were determined by western blot analysis. We observed that miR-195 was downregulated in clear cell renal cell carcinoma samples compared with normal renal samples. We identified that overexpression of miR-195 inhibited ACHN cell viability, migration, invasion, and it also induced cell apoptosis by targeting VEGFR2 via PI3K/Akt and Raf/MEK/ERK signaling pathways. These findings indicate that miR-195 has a tumor suppressive role in ACHN cells and miR-195 may be a promising candidate target for prevention and treatment of renal cell carcinoma.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2016.3608</identifier><identifier>PMID: 27572273</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>ACHN ; Angiogenesis ; Apoptosis ; Cancer therapies ; Carcinoma, Renal cell ; Carcinoma, Renal Cell - genetics ; Care and treatment ; Cell cycle ; Cell growth ; Cell Line, Tumor ; Cell Movement ; clear cell renal cell carcinoma ; Development and progression ; Down-Regulation ; Female ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genetic aspects ; Health aspects ; Humans ; Innovations ; Kidney cancer ; Kidney Neoplasms - genetics ; Male ; MAP Kinase Signaling System ; Medical research ; Metastasis ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; miR-195 ; Molecular targeted therapy ; Neoplasm Invasiveness ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphorylation ; Properties ; Proteins ; Proto-Oncogene Proteins c-akt - metabolism ; Tumor suppressor genes ; Vascular Endothelial Growth Factor Receptor-2 - genetics ; VEGFR2</subject><ispartof>International journal of oncology, 2016-09, Vol.49 (3), p.1155-1163</ispartof><rights>Copyright © 2016, Spandidos Publications</rights><rights>COPYRIGHT 2016 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-d034eeb9359ea03c243b5cd0709d4690365dd0e2e265f2967f64cf10702209853</citedby><cites>FETCH-LOGICAL-c490t-d034eeb9359ea03c243b5cd0709d4690365dd0e2e265f2967f64cf10702209853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,5571,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27572273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Pengcheng</creatorcontrib><creatorcontrib>Wang, Lu</creatorcontrib><creatorcontrib>Lu, Yunhan</creatorcontrib><creatorcontrib>Liu, Yuwei</creatorcontrib><creatorcontrib>Li, Lechen</creatorcontrib><creatorcontrib>Yin, Luyao</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Zhao, Weiming</creatorcontrib><creatorcontrib>Shen, Baozhong</creatorcontrib><creatorcontrib>Xu, Wanhai</creatorcontrib><title>MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we used qRT-PCR to detect the expression of miR-195 in ccRCC tissues and normal kidney tissues. MTT assay was performed to detect the cell viability of miR-195. Migration and invasion were evaluated by Transwell migration and Matrigel invasion assays, respectively. Additionally, apoptosis levels were evaluated using TUNEL assays, and signaling pathway changes were determined by western blot analysis. We observed that miR-195 was downregulated in clear cell renal cell carcinoma samples compared with normal renal samples. We identified that overexpression of miR-195 inhibited ACHN cell viability, migration, invasion, and it also induced cell apoptosis by targeting VEGFR2 via PI3K/Akt and Raf/MEK/ERK signaling pathways. These findings indicate that miR-195 has a tumor suppressive role in ACHN cells and miR-195 may be a promising candidate target for prevention and treatment of renal cell carcinoma.</description><subject>ACHN</subject><subject>Angiogenesis</subject><subject>Apoptosis</subject><subject>Cancer therapies</subject><subject>Carcinoma, Renal cell</subject><subject>Carcinoma, Renal Cell - genetics</subject><subject>Care and treatment</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>clear cell renal cell carcinoma</subject><subject>Development and progression</subject><subject>Down-Regulation</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Innovations</subject><subject>Kidney cancer</subject><subject>Kidney Neoplasms - genetics</subject><subject>Male</subject><subject>MAP Kinase Signaling System</subject><subject>Medical research</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>miR-195</subject><subject>Molecular targeted therapy</subject><subject>Neoplasm Invasiveness</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphorylation</subject><subject>Properties</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Tumor suppressor genes</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - genetics</subject><subject>VEGFR2</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkV1v0zAUhiMEYmNwyS2yhARXaf2d-jKqug91G6gCbi03cVqXJM58nKHt18-lYzAJnQtbPs975KMny94TPGEzRadu5ycUEzlhEs9eZMekUCSnnLKX6Y6JyiVn6ih7A7DDmAqByevsiBaioLRgx9n9lauCX12XOVECRRM2NgL6sTg7XVFk-hptDSCD4tj5gGAchmAB3K1FwbcWuR6V8_NrVNm2BXTrDPp6wZbT8mf8nV2ZZnq1WE4XqyUCt-lN6_oNGkzc_jJ38DZ71ZgW7LvH8yT7frr4Nj_PL7-cXczLy7ziCse8xoxbu1ZMKGswqyhna1HVuMCq5lJhJkVdY0stlaKhShaN5FVDUp9SrGaCnWQfD3OH4G9GC1Hv_BjSZ0ATxWgqTthfamNaq13f-BhM1TmodMklK4TklCRq8h8qVW07V_neNi69Pwt8-iewtaaNW_DtGJ3v4TmYH8CkAyDYRg_BdSbcaYL13rROpvXetN6bTvyHx63GdWfrJ_qP2gR8PgAwJBeu9vDEpEk5VzlmOSFCsAelVaqY</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Sun, Pengcheng</creator><creator>Wang, Lu</creator><creator>Lu, Yunhan</creator><creator>Liu, Yuwei</creator><creator>Li, Lechen</creator><creator>Yin, Luyao</creator><creator>Zhang, Cheng</creator><creator>Zhao, Weiming</creator><creator>Shen, Baozhong</creator><creator>Xu, Wanhai</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20160901</creationdate><title>MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways</title><author>Sun, Pengcheng ; Wang, Lu ; Lu, Yunhan ; Liu, Yuwei ; Li, Lechen ; Yin, Luyao ; Zhang, Cheng ; Zhao, Weiming ; Shen, Baozhong ; Xu, Wanhai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-d034eeb9359ea03c243b5cd0709d4690365dd0e2e265f2967f64cf10702209853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ACHN</topic><topic>Angiogenesis</topic><topic>Apoptosis</topic><topic>Cancer therapies</topic><topic>Carcinoma, Renal cell</topic><topic>Carcinoma, Renal Cell - genetics</topic><topic>Care and treatment</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>clear cell renal cell carcinoma</topic><topic>Development and progression</topic><topic>Down-Regulation</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Innovations</topic><topic>Kidney cancer</topic><topic>Kidney Neoplasms - genetics</topic><topic>Male</topic><topic>MAP Kinase Signaling System</topic><topic>Medical research</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>miR-195</topic><topic>Molecular targeted therapy</topic><topic>Neoplasm Invasiveness</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphorylation</topic><topic>Properties</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Tumor suppressor genes</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - genetics</topic><topic>VEGFR2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Pengcheng</creatorcontrib><creatorcontrib>Wang, Lu</creatorcontrib><creatorcontrib>Lu, Yunhan</creatorcontrib><creatorcontrib>Liu, Yuwei</creatorcontrib><creatorcontrib>Li, Lechen</creatorcontrib><creatorcontrib>Yin, Luyao</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Zhao, Weiming</creatorcontrib><creatorcontrib>Shen, Baozhong</creatorcontrib><creatorcontrib>Xu, Wanhai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Pengcheng</au><au>Wang, Lu</au><au>Lu, Yunhan</au><au>Liu, Yuwei</au><au>Li, Lechen</au><au>Yin, Luyao</au><au>Zhang, Cheng</au><au>Zhao, Weiming</au><au>Shen, Baozhong</au><au>Xu, Wanhai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>49</volume><issue>3</issue><spage>1155</spage><epage>1163</epage><pages>1155-1163</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we used qRT-PCR to detect the expression of miR-195 in ccRCC tissues and normal kidney tissues. MTT assay was performed to detect the cell viability of miR-195. Migration and invasion were evaluated by Transwell migration and Matrigel invasion assays, respectively. Additionally, apoptosis levels were evaluated using TUNEL assays, and signaling pathway changes were determined by western blot analysis. We observed that miR-195 was downregulated in clear cell renal cell carcinoma samples compared with normal renal samples. We identified that overexpression of miR-195 inhibited ACHN cell viability, migration, invasion, and it also induced cell apoptosis by targeting VEGFR2 via PI3K/Akt and Raf/MEK/ERK signaling pathways. These findings indicate that miR-195 has a tumor suppressive role in ACHN cells and miR-195 may be a promising candidate target for prevention and treatment of renal cell carcinoma.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>27572273</pmid><doi>10.3892/ijo.2016.3608</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-6439
ispartof International journal of oncology, 2016-09, Vol.49 (3), p.1155-1163
issn 1019-6439
1791-2423
language eng
recordid cdi_proquest_journals_1932323413
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects ACHN
Angiogenesis
Apoptosis
Cancer therapies
Carcinoma, Renal cell
Carcinoma, Renal Cell - genetics
Care and treatment
Cell cycle
Cell growth
Cell Line, Tumor
Cell Movement
clear cell renal cell carcinoma
Development and progression
Down-Regulation
Female
Gene expression
Gene Expression Regulation, Neoplastic
Genetic aspects
Health aspects
Humans
Innovations
Kidney cancer
Kidney Neoplasms - genetics
Male
MAP Kinase Signaling System
Medical research
Metastasis
MicroRNA
MicroRNAs
MicroRNAs - genetics
miR-195
Molecular targeted therapy
Neoplasm Invasiveness
Phosphatidylinositol 3-Kinases - metabolism
Phosphorylation
Properties
Proteins
Proto-Oncogene Proteins c-akt - metabolism
Tumor suppressor genes
Vascular Endothelial Growth Factor Receptor-2 - genetics
VEGFR2
title MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T04%3A59%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-195%20targets%20VEGFR2%20and%20has%20a%20tumor%20suppressive%20role%20in%20ACHN%20cells%20via%20PI3K/Akt%20and%20Raf/MEK/ERK%20signaling%20pathways&rft.jtitle=International%20journal%20of%20oncology&rft.au=Sun,%20Pengcheng&rft.date=2016-09-01&rft.volume=49&rft.issue=3&rft.spage=1155&rft.epage=1163&rft.pages=1155-1163&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2016.3608&rft_dat=%3Cgale_proqu%3EA463756421%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1932323413&rft_id=info:pmid/27572273&rft_galeid=A463756421&rfr_iscdi=true